Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682058 · ClinicalTrials.gov registry record
Body Composition & REE Responses to Bariatric Surgery
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 106
- Enrollment target
NCT00682058: Completed study, sponsored by Columbia University.
NCT00682058 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00682058 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The aim of this study is to measure important components of weight change in patients who underwent bariatric surgery on measures of fat mass and its distribution and fat-free mass (FFM) (bone mineral density, skeletal muscle, and specific organs) at 60 months (T60) and 84 months (T84) post-surgery, and to compare compartment sizes with stable weight controls.
Interventions
- OTHER Follow-up post-bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-10 |
| Est. Completion | 2018-06 |
What the finished NCT00682058 record still lists
NCT00682058 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Follow-up post-bariatric surgery is the first listed.
NCT00682058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00682058 about?
NCT00682058 is a clinical study titled "Body Composition & REE Responses to Bariatric Surgery". The aim of this study is to measure important components of weight change in patients who underwent bariatric surgery on measures of fat mass and its distribution and fat-free mass (FFM) (bone mineral density, skeletal muscle, and specific organs) at 60 months (T60) and 84 months (T84) post-surgery,...
What is the current status of trial NCT00682058?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2006-10. Estimated completion is 2018-06.
What interventions are being tested in trial NCT00682058?
The interventions under investigation include: Follow-up post-bariatric surgery (OTHER).
Who is sponsoring clinical trial NCT00682058?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia